What is the address of CROBEPHAR?

The registered office of CROBEPHAR is located at Rue de Vellereille(GIV) 41D, 7041 Quévy.

Is CROBEPHAR still active?

Yes. According to the CBE (30 October 2026) CROBEPHAR is active, legal situation “Normale toestand”, started on 4 December 2017.

Is CROBEPHAR registered on Peppol?

Yes, CROBEPHAR is registered on the Peppol network with ID 0208:0685618467.

What is the enterprise number of CROBEPHAR?

The enterprise number of CROBEPHAR is BE0685618467.

When was CROBEPHAR founded?

CROBEPHAR was founded on 4 December 2017.

Who are the directors of CROBEPHAR?

According to the 2025 annual accounts, the directors of CROBEPHAR are: Benoît CROWET.

Is CROBEPHAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 December 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CROBEPHAR make in 2025?

CROBEPHAR posted a profit after taxes of € 115,094 in financial year 2025.

What is the revenue of CROBEPHAR?

As a small company, CROBEPHAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 124,234.

CROBEPHAR (Private Limited) - Quévy - BE0685618467

Q: What does CROBEPHAR do?

CROBEPHAR is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 4 December 2017, 1 establishment.

Dossier CROBEPHAR, printed on 30 October 2026 from databakkes.be/en/0685618467/crobephar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

CROBEPHAR from Quévy, company number BE0685618467, closed financial year 2025 with a result of € 115,094 after tax. For that financial year CROBEPHAR recorded a gross margin of € 124,234 and equity of € 546,012. Compared with financial year 2024, the result moved from € 61,414 to € 115,094. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 20, 2026.

What it is worth Growing

€ 546,012

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 115,094

▲ 87% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 15,756

▲ € 13,265 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 58,850 paid out

51 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 6,704

▲ € 6,086 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 900,695

▼ 8% vs 2024

€ 87,227 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 1,483

▼ 49% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,000

▼ 72% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 68,032 Gross margin 2022: € 68,032 First fiscal year in the series	€ 93,844 Gross margin 2023: € 93,844 ▲ 38% vs 2022 (€ 68,032) Favourable step	€ 108,897 Gross margin 2024: € 108,897 ▲ 16% vs 2023 (€ 93,844) Favourable step	€ 124,234 Gross margin 2025: € 124,234 ▲ 14% vs 2024 (€ 108,897) Favourable step	▲ 14%
Profit after taxes	€ 73,817 Profit after taxes 2022: € 73,817 First fiscal year in the series	€ 86,513 Profit after taxes 2023: € 86,513 ▲ 17% vs 2022 (€ 73,817) Favourable step	€ 61,414 Profit after taxes 2024: € 61,414 ▼ 29% vs 2023 (€ 86,513) Unfavourable step	€ 115,094 Profit after taxes 2025: € 115,094 ▲ 87% vs 2024 (€ 61,414) Favourable step	▲ 87%
Equity	€ 412,455 Equity 2022: € 412,455 First fiscal year in the series	€ 487,203 Equity 2023: € 487,203 ▲ 18% vs 2022 (€ 412,455) Favourable step	€ 489,767 Equity 2024: € 489,767 ▲ 1% vs 2023 (€ 487,203) Favourable step	€ 546,012 Equity 2025: € 546,012 ▲ 11% vs 2024 (€ 489,767) Favourable step	▲ 11%
Total debts	€ 776,904 Total debts 2022: € 776,904 First fiscal year in the series	€ 956,184 Total debts 2023: € 956,184 ▲ 23% vs 2022 (€ 776,904) Unfavourable step	€ 1,042,691 Total debts 2024: € 1,042,691 ▲ 9% vs 2023 (€ 956,184) Unfavourable step	€ 1,013,641 Total debts 2025: € 1,013,641 ▼ 3% vs 2024 (€ 1,042,691) Favourable step	▼ 3%
Cash	€ 13,863 Cash 2022: € 13,863 First fiscal year in the series	€ 12,308 Cash 2023: € 12,308 ▼ 11% vs 2022 (€ 13,863) Unfavourable step	€ 2,491 Cash 2024: € 2,491 ▼ 80% vs 2023 (€ 12,308) Unfavourable step	€ 15,756 Cash 2025: € 15,756 ▲ € 13,265 vs 2024 (€ 2,491) Favourable step	▲ € 13,265
Land & buildings	€ 242,689 Land & buildings 2022: € 242,689 First fiscal year in the series	€ 484,398 Land & buildings 2023: € 484,398 ▲ 100% vs 2022 (€ 242,689) Unchanged	€ 600,906 Land & buildings 2024: € 600,906 ▲ 24% vs 2023 (€ 484,398) Unchanged	€ 596,346 Land & buildings 2025: € 596,346 ▼ 1% vs 2024 (€ 600,906) Unchanged	▼ 1%
Retained profit	€ 362,455 Retained profit 2022: € 362,455 First fiscal year in the series	€ 437,203 Retained profit 2023: € 437,203 ▲ 21% vs 2022 (€ 362,455) Favourable step	€ 439,767 Retained profit 2024: € 439,767 ▲ 1% vs 2023 (€ 437,203) Favourable step	€ 496,012 Retained profit 2025: € 496,012 ▲ 13% vs 2024 (€ 439,767) Favourable step	▲ 13%
Dividend	€ 29,500 Dividend 2022: € 29,500 First fiscal year in the series	€ 11,765 Dividend 2023: € 11,765 ▼ 60% vs 2022 (€ 29,500) Unchanged	€ 58,850 Dividend 2024: € 58,850 ▲ € 47,085 vs 2023 (€ 11,765) Unchanged	€ 58,850 Dividend 2025: € 58,850 Unchanged (€ 58,850) Unchanged
Bank debt	€ 744,351 Bank debt 2022: € 744,351 First fiscal year in the series	€ 941,861 Bank debt 2023: € 941,861 ▲ 27% vs 2022 (€ 744,351) Unfavourable step	€ 977,189 Bank debt 2024: € 977,189 ▲ 4% vs 2023 (€ 941,861) Unfavourable step	€ 900,695 Bank debt 2025: € 900,695 ▼ 8% vs 2024 (€ 977,189) Favourable step	▼ 8%
Balance sheet total	€ 1,189,359 Balance sheet total 2022: € 1,189,359 First fiscal year in the series	€ 1,443,387 Balance sheet total 2023: € 1,443,387 ▲ 21% vs 2022 (€ 1,189,359) Unchanged	€ 1,532,459 Balance sheet total 2024: € 1,532,459 ▲ 6% vs 2023 (€ 1,443,387) Unchanged	€ 1,559,653 Balance sheet total 2025: € 1,559,653 ▲ 2% vs 2024 (€ 1,532,459) Unchanged	▲ 2%

Key figures of CROBEPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CROBEPHAR?

What happened at CROBEPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 20, 2026 New annual accounts for financial year 2025: profit of € 115,094 (▲ 87% vs 2024). Source: NBB ↗
Dec 4, 2017 New establishment in Quévy. KBO
Dec 4, 2017 Start of the company according to the CBE. KBO

In short

From € 73,817 profit in 2022 to € 115,094 profit in 2025.

Paid € 41,355 in corporate taxes since 2022.

Best year ever: 2025, with € 115,094 profit.

Paid out € 158,965 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Benoît CROWET

CROBEPHAR

Pharmacie B.Crowet 100%

Behind CROBEPHAR is Benoît CROWET. It owns 100% of Pharmacie B.Crowet itself.

Directors

According to the 2025 annual accounts

Benoît CROWET

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Vellereille(GIV) 41D

7041 Quévy

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0685.618.467

VAT number

BE 0685.618.467

Registered office

Rue de Vellereille(GIV) 41D, 7041 Quévy

Names & denominations

CROBEPHAR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 December 2017

Peppol

Active · Active since 20 Nov 2020

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van holdings

Detailhandel in farmaceutische producten

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

CROBEPHAR

Warning lights

Financials

What happened to CROBEPHAR?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions